Malignant Glioma (WHO Grade III or IV)
3 clinical trials · Condition
◉ Watch Malignant Glioma (WHO Grade III or IV)
| Record | Firm | Date |
|---|---|---|
| Chronic CED of TPT for Recurrent Malignant Glioma (NCT06666712) | Jeffrey N. Bruce | 2026-06-12 |
| Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma (NCT01989052) | Annick Desjardins | 2014-05-01 |
| Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure (NCT01954030) | Annick Desjardins | 2013-10-01 |
Track Malignant Glioma (WHO Grade III or IV) automatically
Every clearance here is in the API, with alerts when new ones post.